WG
WILENSKY GAIL R Director
Board F
Insider track record Board Director Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by WILENSKY GAIL R, Director. Insider active across 3 companies, notably Quest Diagnostics INC. In total, 27 filings have been logged. History available since 25 May 2021. The latest transaction was disclosed on 17 May 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations 27 total
1,369 shares 0Common Stock SEC:0001022079-23-000112:0
12,727 shares @ US$4.40 34.8% of flow Common Stock SEC:0001628280-23-000247:0
54,511 shares 0Common Stock SEC:0001628280-22-017231:0
1,292 shares 0Common Stock SEC:0001022079-22-000096:0
100 shares 0Common Stock SEC:0001415889-22-003859:0
68 shares 0Common Stock SEC:0001209191-22-021037:0
9,605 shares @ US$5.83 50.0% of flow Common Stock SEC:0001628280-22-000348:0
9,605 shares @ US$5.83 100.0% of flow Common Stock SEC:0001628280-22-000348
103 shares 0Common Stock SEC:0001209191-22-001738
103 shares 0Common Stock SEC:0001209191-22-001738:0
72 shares 0Common Stock SEC:0001209191-21-070060
72 shares 0Common Stock SEC:0001209191-21-070060:0
131 shares 0Common Stock SEC:0001209191-21-059523:0
131 shares 0Common Stock SEC:0001209191-21-059523
82 shares 0Common Stock SEC:0001209191-21-057436:0
82 shares 0Common Stock SEC:0001209191-21-057436
6,111 shares @ US$57.565 50.0% of flow Common Stock SEC:0001022079-21-000113
6,111 shares @ US$57.565 0.0016% mcap 50.0% of flow Common Stock SEC:0001022079-21-000113:0
7 shares 0Common Stock SEC:0001209191-21-045545
7 shares 0Common Stock SEC:0001209191-21-045545:0
85 shares 0Common Stock SEC:0001209191-21-044495:0
85 shares 0Common Stock SEC:0001209191-21-044495
19,759 shares 0Common Stock SEC:0001209191-21-040906:0
19,759 shares 0Common Stock SEC:0001209191-21-040906
1,363 shares 0Common Stock SEC:0001022079-21-000094
25 of 27 declarations
Load more (2 remaining) About WILENSKY GAIL R Gail R. Wilensky is an insider at Quest Diagnostics Inc.